Shave Biopsy for Suspected Squamous Cell Carcinoma
Shave biopsy is an acceptable and appropriate technique for evaluating suspected squamous cell carcinoma, provided it is performed as a deep saucerization or scoop technique that penetrates adequately into the dermis. 1
Recommended Biopsy Techniques
The American Academy of Dermatology guidelines explicitly endorse three biopsy methods for suspected SCC: 1, 2
- Punch biopsy – provides full-thickness tissue through the dermis
- Shave biopsy (deep tangential/saucerization technique) – must penetrate deep into the dermis, not just superficial tangential removal
- Excisional biopsy – removes the entire lesion with narrow margins for diagnostic purposes
The critical distinction is that "shave biopsy" in this context refers to saucerization or scoop techniques that may penetrate deep into the dermis, not superficial tangential shaves. 1
Essential Requirements for Adequate Sampling
Regardless of which technique you choose, the biopsy specimen must meet specific depth and size criteria: 1, 3
- Adequate depth to capture potential aggressive growth patterns (depth >2 mm, Clark level IV or greater, perineural invasion) 1
- Sufficient size to provide accurate diagnosis and guide therapy 1
- Deep enough sampling to avoid missing invasive components in what may appear clinically as in situ disease 4, 5
Critical Evidence on Diagnostic Accuracy
Studies comparing biopsy methods for nonmelanoma skin cancers demonstrate that punch or shave biopsies can detect relevant histologic characteristics for the vast majority of sampled SCC tumors. 1 However, there are important caveats:
- Approximately 16-31% of biopsy-proven SCC in situ cases are upstaged to invasive SCC upon more complete histologic examination 4, 5
- Lesions with clinical signs of residual tumor (scales, papular changes) and diameter >1.4 cm are more likely to harbor invasive disease 5
- Superficial biopsies may miss aggressive histologic subtypes present only at deeper margins 6
When to Consider More Extensive Sampling
You should perform more extensive tissue resection or multiple scouting biopsies when: 1
- Recurrent tumor is suspected
- Deep invasion is clinically apparent
- Aggressive features are suspected (poorly defined borders, location on high-risk anatomic sites, immunosuppressed patient)
- The lesion is located on the ears, nose, lips, or eyelids with diameter >10 mm 4
Critical Information to Provide the Pathologist
When submitting the biopsy specimen, document these essential elements: 1, 3
- Patient age and biological sex
- Anatomic location of the tumor
- History of prior treatment at the same site
- Clinical size of the lesion
- Risk factors: immunosuppression status, radiation treatment history, solid organ transplantation
Common Pitfalls to Avoid
Never perform a superficial tangential shave biopsy for suspected SCC, as this frequently misses aggressive components and leads to undertreatment. 7 The American Academy of Dermatology specifically advises against treating suspected SCC with destructive methods like cryotherapy without first obtaining a diagnostic biopsy. 2
Consider repeat biopsy if: 1
- The initial specimen is inadequate for accurate diagnosis
- There is tumor transection at the base
- Clinical suspicion suggests aggressive features but histology shows only superficial involvement
Comparison to Other Skin Cancers
While shave biopsy is acceptable for SCC, note that for suspected melanoma, narrow excisional biopsy with 1-3 mm margins is the gold standard, and superficial shave biopsies are generally discouraged as they may underestimate Breslow thickness. 1, 3 The exception is broad shave biopsy for suspected melanoma in situ, lentigo maligna type. 1